[go: up one dir, main page]

AU2022219942A9 - Methods and compositions for cryopreservation of immune cells - Google Patents

Methods and compositions for cryopreservation of immune cells

Info

Publication number
AU2022219942A9
AU2022219942A9 AU2022219942A AU2022219942A AU2022219942A9 AU 2022219942 A9 AU2022219942 A9 AU 2022219942A9 AU 2022219942 A AU2022219942 A AU 2022219942A AU 2022219942 A AU2022219942 A AU 2022219942A AU 2022219942 A9 AU2022219942 A9 AU 2022219942A9
Authority
AU
Australia
Prior art keywords
cryopreservation
compositions
methods
immune cells
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022219942A
Other versions
AU2022219942A1 (en
Inventor
Lan Cao
Dayong Gao
Jiusong SUN
Yana WANG
Qiong XUE
Shuxia Zhou
Huang ZHU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2022/015626 external-priority patent/WO2022173736A1/en
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Priority claimed from PCT/US2022/015869 external-priority patent/WO2022173866A1/en
Publication of AU2022219942A1 publication Critical patent/AU2022219942A1/en
Publication of AU2022219942A9 publication Critical patent/AU2022219942A9/en
Pending legal-status Critical Current

Links

AU2022219942A 2021-02-09 2022-02-09 Methods and compositions for cryopreservation of immune cells Pending AU2022219942A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163147739P 2021-02-09 2021-02-09
US63/147,739 2021-02-09
PCT/US2022/015626 WO2022173736A1 (en) 2021-02-09 2022-02-08 Methods and compositions for cryopreservation of immune cells
AUPCT/US2022/015626 2022-02-08
PCT/US2022/015869 WO2022173866A1 (en) 2021-02-09 2022-02-09 Methods and compositions for cryopreservation of immune cells

Publications (2)

Publication Number Publication Date
AU2022219942A1 AU2022219942A1 (en) 2023-08-17
AU2022219942A9 true AU2022219942A9 (en) 2025-03-06

Family

ID=80785214

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022219942A Pending AU2022219942A1 (en) 2021-02-09 2022-02-09 Methods and compositions for cryopreservation of immune cells

Country Status (2)

Country Link
AU (1) AU2022219942A1 (en)
WO (1) WO2022173866A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024218688A1 (en) 2023-04-18 2024-10-24 Board Of Regents, The University Of Texas System Bcma chimeric antigen receptors and uses thereof
CN116439230B (en) * 2023-04-23 2025-09-26 博生吉安科细胞技术有限公司 A CAR-T cell freezing solution and freezing method
WO2025104700A2 (en) * 2023-11-16 2025-05-22 Takeda Pharmaceutical Company Limited Improved methods for cryopreservation and fitness of natural killer cells, and compositions thereof
WO2025191531A1 (en) 2024-03-15 2025-09-18 Takeda Pharmaceutical Company Limited Cd19 targeting car nk cells in treating systemic lupus erythematosus and lupus nephritis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5996533B2 (en) * 2010-07-13 2016-09-21 アントフロゲネシス コーポレーション How to generate natural killer cells
WO2016063208A1 (en) * 2014-10-20 2016-04-28 Stempeutics Research Pvt. Ltd. A cryopreservation composition and methods thereof

Similar Documents

Publication Publication Date Title
AU2022219942A9 (en) Methods and compositions for cryopreservation of immune cells
EP3962267A4 (en) Composition and method for cryopreservation of cells
AU2022344251A1 (en) Serpina-modulating compositions and methods
EP3873549A4 (en) Compositions and methods for cryopreservation and reconstitution of engineered tissues
AU2022342169A1 (en) Hbb-modulating compositions and methods
EP3931305A4 (en) Compositions and methods for long term culture of hepatocytes
EP4181910A4 (en) Oligosaccharide compositions and methods of use
EP4381022A4 (en) Compositions and methods of use thereof
EP4240379A4 (en) Methods and compositions for enhancing efficacy of therapeutic immune cells
AU2022342168A1 (en) Pah-modulating compositions and methods
EP4326291A4 (en) Methods and compositions for genetic modification and therapeutic use of immune cells
EP3829296A4 (en) Compositions for transportation and/or cryopreservation of cells and/or tissues
EP4251175A4 (en) Adipogenic cell compositions and methods
CA3208280A1 (en) Methods and compositions for cryopreservation of immune cells
EP4359004A4 (en) Compositions and methods for increasing the efficacy of immunotherapies and vaccines
EP4288062A4 (en) Fospropofol methods and compositions
HK40083995A (en) Compositions and methods of cryopreserving cells
HK40060157A (en) Compositions and methods for the cryopreservation of immune cells
HK40076971A (en) Allogeneic cell compositions and methods of use
CA3297128A1 (en) Compositions and methods for cryopreserving cells
HK40117620A (en) Compositions and methods for expression of il-12 and il-1ra
HK40102493A (en) Compositions comprising regulatory t cells and methods of using the same
HK40114042A (en) Persistent allogeneic modified immune cells and methods of use thereof
AU2021904196A0 (en) Methods and Preparation and Uses of Xanthorrhoeaceae Compositions
HK40056325A (en) Allogeneic cell compositions and methods of use